Snap Diagnostics Funding: How Much Did They Raise & Key Investors

How Much Did Snap Diagnostics Raise?
Funding & Key Investors

Snap Diagnostics, a company focused on obstructive sleep apnea solutions, has secured $2.5M in total capital, with its most recent financing round bringing in $1.5M in a major strategic investment. This significant backing underscores the company's established presence and ongoing development within the medical device sector.

What is Snap Diagnostics?

Snap Diagnostics

Manufacturing

Medical Devices & Equipment

Healthcare Services

Founded in 1994 and headquartered in Wheeling, Illinois, SNAP Diagnostics is a private medical device and service company. Its core mission revolves around the development, manufacturing, and marketing of products designed to aid in the diagnosis, analysis, and management of obstructive sleep apnea. The company's long-standing commitment to this critical health area positions it as a key player in the sleep disorder diagnostics market.

How much funding has Snap Diagnostics raised?

Snap Diagnostics has raised a total of $2.5M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$1.5M

Debt (2020): $1M with participation from PPP

Debt (2021): $1.5M led by PPP

Key Investors in Snap Diagnostics

PPP

Public-Private Partnership

PPP

Public-Private Partnership

What's next for Snap Diagnostics?

The recent major strategic investment, alongside the substantial total funding of $2.5M, indicates a phase of significant growth and potential expansion for Snap Diagnostics. This capital infusion is likely to fuel further research and development into advanced diagnostic tools, enhance manufacturing capabilities, and broaden market reach. The company's focus on a prevalent health issue like sleep apnea suggests a strategic direction aimed at capturing a larger share of a growing market, potentially through new product launches or strategic partnerships.

See full Snap Diagnostics company page

See More Financial Insights